{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-022358","form_type":"8-K","ticker":"VXRT","cik":"0000072444","company_name":"Vaxart, Inc.","filed_at":"2025-07-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.236646+00:00","generated_at":"2026-05-18T09:13:01.280464+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Vaxart delisted from Nasdaq, begins trading on OTCQX after bid price failure","bullets":["Nasdaq delisted VXRT for non-compliance with minimum bid price requirement (Rule 5550(a)(2)).","Trading suspended on Nasdaq July 8, 2025; stock began same-day trading on OTCQX Best Market under same ticker.","Vaxart appealed the delisting on July 3, 2025; shares remain suspended on Nasdaq pending hearing panel decision.","CEO Steven Lo says focus remains on advancing oral pill vaccine pipeline while considering listing options."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-022358","json":"https://secwatch.observer/filing/0001437749-25-022358.json","markdown":"https://secwatch.observer/filing/0001437749-25-022358.md","text":"https://secwatch.observer/filing/0001437749-25-022358.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/72444/000143774925022358/0001437749-25-022358-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/72444/000143774925022358/vxrt20250708_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:13:01.280464+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}